Finerenone in Patients With CKD and Type 2 Diabetes Receiving SGLT2 Inhibitor Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Diabetes Care 2022 Aug 15;[EPub Ahead of Print], P Rossing, SD Anker, G Filippatos, B Pitt, LM Ruilope, AL Birkenfeld, JB McGill, SE Rosas, A Joseph, M Gebel, L Roberts, MF Scheerer, GL Bakris, R AgarwalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.